HopeStage
Back to all studies
CompletedNCT02147379

Cognition During Lurasidone Treatment for Bipolarity

About this title

Lurasidone and Cognition in Bipolar I Disorder

Read the official source — NCT02147379
Medication studyAges 19–65Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 65 years.

Listed locations
VancouverSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2014
Recruitment status
Completed
Enrollment listed in the registry
53
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 19 Years to 65 Years
Official registry ID
NCT02147379
Official title
Show the full official title

Changes in Cognitive Functioning in Euthymic Bipolar Patients Treated With Lurasidone Versus Treatment as Usual; A Randomized, Open-Label Study.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Did this study involve medication?

Yes. The study involved medication, including Lurasidone.

Who was this study for?

Listed age limits: 19 years to 65 years.

Want to explore more studies?

Explore studies